Carl June-FDA 2017 Kymriah-Yescarta CAR-T-CD19; modern modern foundational + bispecific BiTE blinatumomab + 2024 in-vivo CAR-T mRNA Pfizer.
Carl June-FDA 2017 Kymriah-Yescarta CAR-T-CD19; modern modern foundational + bispecific BiTE blinatumomab + 2024 in-vivo CAR-T mRNA Pfizer.